Skip to main navigation
Amgen Logo Amgen Logo
  • Main Menu
  • About
    • Overview
    • Amgen History
    • Mission and Values
    • Leadership
    • Amgen Foundation
    • Awards and Accolades
    • Therapy Areas
      • Cardiovascular Metabolic
      • Bone Health
      • Inflammation
      • Oncology
    • How We Operate
      • Overview
      • Corporate Governance
      • Business Ethics and Compliance
      • Policies, Practices and Disclosures
  • Science
    • Overview
    • Research & Development Strategy
      • Overview
      • Human & Disease Biology
      • Novel Targets & Modalities
      • Clinical Trial Optimization
      • AI & Data Science
    • Pipeline
    • Scientific Advisory Boards
    • Biosimilars
    • Clinical Trials
      • Overview
      • About Clinical Trials
      • Amgen Clinical Trials
      • Clinical Trial Diversity and Representation
      • Information for Healthcare Professionals
      • Clinical Trial Transparency, Data Sharing and Disclosure Practices
      • Clinical Out-of-Hours Support program
      • Investigator Sponsored Studies
    • Scientific Community Initiatives   
      • Overview
      • Educational Outreach Program
      • Postdoctoral Fellows Program
      • Scientific Conferences Program
      • Start-Up Network Program
    • Manufacturing
      • Overview
      • Innovation
      • Quality
      • Reliability
  • PRODUCTS
    • Overview
    • Medical Information
    • Counterfeit Drug Statement
    • Safety Data Sheets
    • Global Patient Safety
      • Overview
      • Who We Are
      • Our Commitment
      • What We Do
      • Adverse Event and Product Complaint Reporting
  • Responsibility
    • Overview
    • Annual Sustainability Highlights Report
    • Corporate Sustainability Strategy
    • Healthy Patients & Communities
      • Overview
      • Access to Healthcare
      • Health Equity
      • Community Investment and Amgen Foundation
      • Product Quality
      • Patient Safety
    • Healthy Planet
      • Overview
      • Environmental Sustainability
      • Responsible Sourcing
    • Healthy Amgen
      • Overview
      • Our Workforce
      • Corporate Governance
      • Business Ethics and Compliance
      • Ethical Research and Development
      • Cybersecurity and Data Privacy
    • Reporting and Metrics
      • Overview
      • CDP
      • Archived Reports
  • Stories
    • All Stories
    • Responsibility
    • People and Culture
    • Science and Innovation
    • Patients
    • Leadership
  • Newsroom
  • Partners
  • Investors
  • Careers
  • Amgen Worldwide
    • linkedIn-icon linkedIn-icon
    • twitter-icon twitter-icon
    • youtube-icon youtube-icon
    • facebook-icon
    • instagram-icon instagram-icon
  • All Stories
  • Responsibility
  • People and Culture
  • Science and Innovation
  • Patients
  • Leadership
  • Popular Tags
  • COVID-19
  • Supporting Our Staff
  • Leveraging Our Science
  • Serving Our Communities
  • All Stories
  • Responsibility
  • People and Culture
  • Science and Innovation
  • Patients
  • Leadership
  • Popular Tags
  • COVID-19
  • Supporting Our Staff
  • Leveraging Our Science
  • Serving Our Communities
Amgen Logo Amgen Logo
  • About
    • Overview
    • Amgen History
    • Mission and Values
    • Leadership
    • Amgen Foundation
    • Therapy Areas
    • General Medicine
    • Rare Disease
    • Inflammation
    • Oncology
    • Awards and Accolades
    • How We Operate
    • Corporate Governance
    • Business Ethics and Compliance
    • Policies, Practices and Disclosures
  • Science
    • Overview
    • Research & Development Strategy
    • Human & Disease Biology
    • Novel Targets & Modalities
    • Clinical Trial Optimization
    • AI in Research & Development
    • Pipeline
    • Scientific Advisory Boards
    • Biosimilars
    • Clinical Trials
    • About Clinical Trials
    • Amgen Clinical Trials
    • Clinical Trial Diversity and Representation
    • Information for Healthcare Professionals
    • Clinical Trial Transparency, Data Sharing and Disclosure Practices
    • Clinical Out-of-Hours Support Program
    • Investigator Sponsored Studies
    • Scientific Community Initiatives
    • Educational Outreach Program
    • Postdoctoral Fellows Program
    • Scientific Conferences Program
    • Start-Up Network Program
    • Manufacturing
    • Innovation
    • Quality
    • Reliability
  • PRODUCTS
    • Overview
    • Medical Information
    • Counterfeit Drug Statement
    • Safety Data Sheets
    • Global Patient Safety
    • Who We Are
    • Our Commitment
    • What We Do
    • Adverse Event and Product Complaint Reporting
  • Responsibility
    • Overview
    • Annual Sustainability Highlights Report
    • Corporate Sustainability Strategy
    • Healthy Patients & Communities
    • Access to Healthcare
    • Health Equity
    • Amgen Foundation and Community Investment
    • Product Quality
    • Patient Safety
    • Healthy Planet
    • Environmental Sustainability
    • Responsible Sourcing
    • Healthy Amgen
    • Our Workforce
    • Corporate Governance
    • Business Ethics and Compliance
    • Ethical Research and Development
    • Cybersecurity and Data Privacy
    • Reporting and Metrics
    • CDP
    • Archived Reports
  • Stories
    • All Stories
    • Responsibility
    • People and Culture
    • Science and Innovation
    • Patients
    • Leadership
  • Newsroom
  • Partners
  • Investors
  • Careers

Breadcrumb

  1. Home
  2. Investors
  3. Annual Reports

Annual Reports

  • Investors
    • About
    • Leadership
    • Mission and Values
  • News & Events
    • Press Releases
    • Presentations
    • Events Calendar
    • Annual Meeting
  • Financials
    • SEC Filings
    • Quarterly Earnings
    • Annual Reports
    • Tax Forms
    • Reconciliations
  • Pipeline
  • Stock
    • Stock Information
    • Dividend Information
    • Fundamentals
  • Corporate Sustainability
    • Corporate Governance
    • Responsibility
    • Environment
    • Diversity, Inclusion & Belonging
    • Green Bond
      • Amgen Green Bond Allocation Report
      • Amgen Green Financing Framework 2022
      • Second-party opinion (SPO) on the bond framework
  • Resources
    • FAQs
    • Email Alerts
    • Investor Contacts
03.31.2026
Chairman and CEO Letter and Amgen Inc. 2025 Annual Report 15.9 MB
04.02.2025
Chairman and CEO Letter and Amgen Inc. 2024 Annual Report 6.5 MB
04.10.2024
Chairman and CEO Letter and Amgen Inc. 2023 Annual Report 8.1 MB
03.30.2023
Chairman and CEO Letter and Amgen Inc. 2022 Annual Report 16.9 MB
03.29.2022
Chairman and CEO Letter and Amgen Inc. 2021 Annual Report 3.7 MB
03.30.2021
Chairman and CEO Letter and Amgen Inc. 2020 Annual Report 3.6 MB
03.31.2020
Chairman and CEO Letter and Amgen Inc. 2019 Annual Report 12.6 MB
04.03.2019
Chairman and CEO Letter and Amgen Inc. 2018 Annual Report 8.7 MB
04.04.2018
Chairman and CEO Letter and Amgen Inc. 2017 Annual Report 7.1 MB
04.03.2017
Chairman and CEO Letter and Amgen Inc. 2016 Annual Report 2.3 MB
03.31.2016
Chairman and CEO Letter and Amgen Inc. 2015 Annual Report 1.3 MB
04.02.2015
2015 Proxy Statement 4 MB
03.26.2015
Chairman and CEO Letter and Amgen Inc. 2014 Annual Report 2.5 MB
03.27.2014
Chairman and CEO Letter and Amgen Inc. 2013 Annual Report 2.5 MB
04.04.2013
Chairman and CEO Letter and Amgen Inc. 2012 Annual Report 1.2 MB
04.12.2012
2011 Annual Report and 10-K 15.2 MB
04.06.2011
2010 Annual Report and 10-K 4.6 MB
03.23.2010
2009 Annual Report and 10-K 4.1 MB
03.17.2009
2008 Annual Report and 10-K 2.3 MB
03.19.2008
2007 Annual Report and 10-K 7.6 MB
03.19.2007
2006 Annual Report 5.5 MB
02.28.2007
2006 10-K 902.6 KB
03.20.2006
2005 Annual Report 4.8 MB
03.10.2006
2005 10-K 1.1 MB
12.31.2004
2004 Annual Report 3.9 MB
12.31.2004
2004 10-K 380.2 KB
12.31.2003
2003 10-K 820.9 KB
12.31.2003
2003 Annual Report 974.8 KB
12.31.2002
2002 10-K 449.2 KB
12.31.2002
2002 Annual Report 5.1 MB
12.31.2001
2001 Annual Report 1.2 MB
12.31.2000
2000 Annual Report 2.6 MB
Navbar w/ text
  • Investors
    • About
    • Leadership
    • Mission and Values
  • News & Events
    • Press Releases
    • Presentations
    • Events Calendar
    • Annual Meeting
  • Financials
    • SEC Filings
    • Quarterly Earnings
    • Annual Reports
    • Tax Forms
    • Reconciliations
  • Pipeline
  • Stock
    • Stock Information
    • Dividend Information
    • Fundamentals
  • Corporate Sustainability
    • Corporate Governance
    • Responsibility
    • Environment
    • Diversity, Inclusion & Belonging
    • Green Bond
      • Amgen Green Bond Allocation Report
      • Amgen Green Financing Framework 2022
      • Second-party opinion (SPO) on the bond framework
  • Resources
    • FAQs
    • Email Alerts
    • Investor Contacts

Earnings

Show all
Q1 2026
  • Amgen Q1 2026 Earnings Conference Call
  • AMGEN REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
  • Q1 2026 Earnings Presentation 2.9 MB
ALL RESULTS 

Data as of:

Minimum 15 minutes delayed. Source: LSEG

MORE STOCK
d-amgen-logo m-amgen-logo
Stay Connected With Amgen.
  • linkedIn-icon linkedIn-icon
  • twitter-icon twitter-icon
  • youtube-icon youtube-icon
  • facebook-icon
  • instagram-icon instagram-icon
Contact Us Sitemap Privacy Statement Terms of Use

© 1996-2020 Amgen Inc. All Rights Reserved. /sites/g/files/knoqqb60211/themes/site/nir_pid3019/dist/images/d-amgen-logo.svg